RESEARCH-USE BIOSIMILAR ANTIBODY
Uliledlimab
Monoclonal antibody · IgG1
Uliledlimab is a potent against CD73 humanizedized monoclonal antibody. Uliledlimab inhibits the conversion of extracellular adenosine monophosphate (AMP) to adenosine. Uliledlimab can be used in research of cancer.
TARGETCD73
YMonoclonal antibody
CATALOGSC-BS-077
CATALOG NUMBERSC-BS-077
MOLECULAR WEIGHTApprox. 145.04 kDa
PRODUCT FORMATMonoclonal antibody
PRODUCT OVERVIEW
A research-use configuration for comparative antibody studies
Uliledlimab is a potent against CD73 humanizedized monoclonal antibody. Uliledlimab inhibits the conversion of extracellular adenosine monophosphate (AMP) to adenosine. Uliledlimab can be used in research of cancer.
Uliledlimab is a recombinant research-use antibody directed against CD73.